chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 25.0
Sex: M
Vaccine: FLUN(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Protein total increased, Red blood cell sedimentation rate normal, Staphylococcus test negative, Tarsal tunnel syndrome, Ulnar tunnel syndrome
Clinical narrative: This report to VAERS provides the following narrative: A report received from VAERS (Health Authority) concerns a 25 year old male. Patient's relevant history and concomitant disease were not reported. Concomitant medications included multiple vaccinations. The patient received FLUMIST (intranasal) vaccine on 16-Mar-2010 together with: Tdap, hepatitis A vaccine, hepatitis B vaccine, meningococcal polysaccharide and H1N1, intranasal vaccines. The patient reported on medical on 29-Mar-2010 with complaints of 4 day history of numbness and tingling in his great toes, back of his legs, fingertips, lower back and gluteus medius. The patient followed-up in medical on 30-Mar-2010 with additional complaints of weakness in his thighs and balance problems. At this time he also mentioned that he had a 5 day history of a productive cough (white mucous; no other symptoms; many other members with cough also). The patient was seen by a neurologist who documented mild leg weakness in association with absent deep tendon reflexes. The patient was admitted to hospital with the diagnosis of lumbosacral radiculopathy, carpal tunnel syndrome, Guyon's canal syndrome and tarsal tunnel syndrome. The patient was discharged on 31-Mar-2010. On 04-Apr-2010 the patient complained of facial numbness (more on left than right), no difficulty swallowing or breathing. An LP (lumbar puncture) was performed in the ER and the patient was admitted to hospital with the diagnosis of GBS. He subsequently developed bilateral facial paresis in a peripheral nerve distribution. He did experience very mild dysphagia for thin liquids and was briefly placed on a thickened liquid diet. He received a 3 day course of IVIG at a dose of 0.8gm/kg/day. The patient did experience a few episodes of orthostasis with nausea, emesis and headache which were attributed to autonomic instability from the GBS. This had resolved. As of 16-Apr-2010 his dysphagia has resolved and his bifacial paresis, ataxia and strength have improved significantly. Remaining deficits included: mild left peripheral facial weakness with diminished strength of lid closure of the left, absent deep tendon reflexes (except for bilateral biceps brachii). At the time of reporting, the event of Guillain Barre Syndrome was improving. The outcome of the events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough was unknown. Laboratory values and diagnostic test details were available. The reporter assessed the event of Guillain Barre Syndrome to be serious due to criteria of hospitalization. Events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough were identified and captured by the company physician as serious by the criterion of hospitalization.
Age: 25.0
Sex: M
Vaccine: FLUN(H1N1), FLUN3, HEPAB, MNQ, TDAP
Symptoms: Vitamin B12 increased, Vomiting, White blood cell count increased
Clinical narrative: This report to VAERS provides the following narrative: A report received from VAERS (Health Authority) concerns a 25 year old male. Patient's relevant history and concomitant disease were not reported. Concomitant medications included multiple vaccinations. The patient received FLUMIST (intranasal) vaccine on 16-Mar-2010 together with: Tdap, hepatitis A vaccine, hepatitis B vaccine, meningococcal polysaccharide and H1N1, intranasal vaccines. The patient reported on medical on 29-Mar-2010 with complaints of 4 day history of numbness and tingling in his great toes, back of his legs, fingertips, lower back and gluteus medius. The patient followed-up in medical on 30-Mar-2010 with additional complaints of weakness in his thighs and balance problems. At this time he also mentioned that he had a 5 day history of a productive cough (white mucous; no other symptoms; many other members with cough also). The patient was seen by a neurologist who documented mild leg weakness in association with absent deep tendon reflexes. The patient was admitted to hospital with the diagnosis of lumbosacral radiculopathy, carpal tunnel syndrome, Guyon's canal syndrome and tarsal tunnel syndrome. The patient was discharged on 31-Mar-2010. On 04-Apr-2010 the patient complained of facial numbness (more on left than right), no difficulty swallowing or breathing. An LP (lumbar puncture) was performed in the ER and the patient was admitted to hospital with the diagnosis of GBS. He subsequently developed bilateral facial paresis in a peripheral nerve distribution. He did experience very mild dysphagia for thin liquids and was briefly placed on a thickened liquid diet. He received a 3 day course of IVIG at a dose of 0.8gm/kg/day. The patient did experience a few episodes of orthostasis with nausea, emesis and headache which were attributed to autonomic instability from the GBS. This had resolved. As of 16-Apr-2010 his dysphagia has resolved and his bifacial paresis, ataxia and strength have improved significantly. Remaining deficits included: mild left peripheral facial weakness with diminished strength of lid closure of the left, absent deep tendon reflexes (except for bilateral biceps brachii). At the time of reporting, the event of Guillain Barre Syndrome was improving. The outcome of the events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough was unknown. Laboratory values and diagnostic test details were available. The reporter assessed the event of Guillain Barre Syndrome to be serious due to criteria of hospitalization. Events of lumbosacral radiculopathy, Guyon's canal syndrome/carpal tunnel syndrome/tarsal tunnel syndrome and productive cough were identified and captured by the company physician as serious by the criterion of hospitalization.
Age: 31.0
Sex: M
Vaccine: FLUN3
Symptoms: Affective disorder, Alanine aminotransferase increased, Anxiety, Asthenia, Balance disorder
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 31 year old, male patient. The patient's medical history included attention deficit disorder, epiglottis at age 3, tracheotomy, severe acne and vasectomy. Patient received FLUMIST (Intranasal) started on 31-Aug-2009. The patient experienced Guillain Barre syndrome which started on 12-Oct-2009. Patient had been having pain in legs requiring opioids, difficulty walking, leg weakness worse. Stands unsteady, drags right foot. Sensation and proprioception subjectively decreased in right leg. IVIG administered. Continued antalgic gait, pain in thighs. 18-Nov-2009 Physical Medicine Rehabilitation, additional hospital consults received service dates 29-Nov-2009 to 16-Nov-2009. Assessment: Relapse of Guillain-Barre Transferred from another hospital and admitted for rehabilitation for Guillain-Barre. Four weeks ago had weakness in upper and lower extremities, diagnosed with Guillain-Barre syndrome, treated with IVIG. Went to rehab and had seizure like episodes. on 04-Nov-2009 increased pain, increased weakness. Presumed diagnosis of relapse of Guillain-Barre with administration of IVIG. Possible seizure symptoms vs anxiety attack. Claustrophobia, Mild facial asymmetry. Deep tendon reflexes decreased. Pain inner thighs, legs hurt. Right-sided head pain diagnosed as migraine. Hands still painful. Numbness in feet persists. Complaints of vision problems and some difficulty urinating. Hyperventilation due to anxiety. Anxiety/Mood disorder. Patient complained of losing vision, dizziness, neuromuscular complaints. Eye exam was normal with exception of extraocular movements due to nystagmus. Neuro exam: normal. Patient presented to the hospital with extreme weakness, pain, trouble sleeping and anxious. Treatment: VICODIN, but no help. Patient saw a psychiatrist. Other treatment: XANAX, Klonopin, CYMBALTA. On examination, patient fatigued, anxiety, vision problems. Impression: Myopathy. Dr's opinion was that this was emotional related event. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event of Guillain Barre syndrome to be serious due to hospitalization. Laboratory values and diagnostic test details are available.
Age: 31.0
Sex: M
Vaccine: FLUN3
Symptoms: Blindness, Blood sodium decreased, Claustrophobia, Dizziness, Dysstasia
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 31 year old, male patient. The patient's medical history included attention deficit disorder, epiglottis at age 3, tracheotomy, severe acne and vasectomy. Patient received FLUMIST (Intranasal) started on 31-Aug-2009. The patient experienced Guillain Barre syndrome which started on 12-Oct-2009. Patient had been having pain in legs requiring opioids, difficulty walking, leg weakness worse. Stands unsteady, drags right foot. Sensation and proprioception subjectively decreased in right leg. IVIG administered. Continued antalgic gait, pain in thighs. 18-Nov-2009 Physical Medicine Rehabilitation, additional hospital consults received service dates 29-Nov-2009 to 16-Nov-2009. Assessment: Relapse of Guillain-Barre Transferred from another hospital and admitted for rehabilitation for Guillain-Barre. Four weeks ago had weakness in upper and lower extremities, diagnosed with Guillain-Barre syndrome, treated with IVIG. Went to rehab and had seizure like episodes. on 04-Nov-2009 increased pain, increased weakness. Presumed diagnosis of relapse of Guillain-Barre with administration of IVIG. Possible seizure symptoms vs anxiety attack. Claustrophobia, Mild facial asymmetry. Deep tendon reflexes decreased. Pain inner thighs, legs hurt. Right-sided head pain diagnosed as migraine. Hands still painful. Numbness in feet persists. Complaints of vision problems and some difficulty urinating. Hyperventilation due to anxiety. Anxiety/Mood disorder. Patient complained of losing vision, dizziness, neuromuscular complaints. Eye exam was normal with exception of extraocular movements due to nystagmus. Neuro exam: normal. Patient presented to the hospital with extreme weakness, pain, trouble sleeping and anxious. Treatment: VICODIN, but no help. Patient saw a psychiatrist. Other treatment: XANAX, Klonopin, CYMBALTA. On examination, patient fatigued, anxiety, vision problems. Impression: Myopathy. Dr's opinion was that this was emotional related event. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event of Guillain Barre syndrome to be serious due to hospitalization. Laboratory values and diagnostic test details are available.
Age: 31.0
Sex: M
Vaccine: FLUN3
Symptoms: Dysuria, Electroencephalogram abnormal, Emotional disorder, Eye movement disorder, Facial asymmetry
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 31 year old, male patient. The patient's medical history included attention deficit disorder, epiglottis at age 3, tracheotomy, severe acne and vasectomy. Patient received FLUMIST (Intranasal) started on 31-Aug-2009. The patient experienced Guillain Barre syndrome which started on 12-Oct-2009. Patient had been having pain in legs requiring opioids, difficulty walking, leg weakness worse. Stands unsteady, drags right foot. Sensation and proprioception subjectively decreased in right leg. IVIG administered. Continued antalgic gait, pain in thighs. 18-Nov-2009 Physical Medicine Rehabilitation, additional hospital consults received service dates 29-Nov-2009 to 16-Nov-2009. Assessment: Relapse of Guillain-Barre Transferred from another hospital and admitted for rehabilitation for Guillain-Barre. Four weeks ago had weakness in upper and lower extremities, diagnosed with Guillain-Barre syndrome, treated with IVIG. Went to rehab and had seizure like episodes. on 04-Nov-2009 increased pain, increased weakness. Presumed diagnosis of relapse of Guillain-Barre with administration of IVIG. Possible seizure symptoms vs anxiety attack. Claustrophobia, Mild facial asymmetry. Deep tendon reflexes decreased. Pain inner thighs, legs hurt. Right-sided head pain diagnosed as migraine. Hands still painful. Numbness in feet persists. Complaints of vision problems and some difficulty urinating. Hyperventilation due to anxiety. Anxiety/Mood disorder. Patient complained of losing vision, dizziness, neuromuscular complaints. Eye exam was normal with exception of extraocular movements due to nystagmus. Neuro exam: normal. Patient presented to the hospital with extreme weakness, pain, trouble sleeping and anxious. Treatment: VICODIN, but no help. Patient saw a psychiatrist. Other treatment: XANAX, Klonopin, CYMBALTA. On examination, patient fatigued, anxiety, vision problems. Impression: Myopathy. Dr's opinion was that this was emotional related event. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event of Guillain Barre syndrome to be serious due to hospitalization. Laboratory values and diagnostic test details are available.
Age: 31.0
Sex: M
Vaccine: FLUN3
Symptoms: Fatigue, Gait disturbance, Guillain-Barre syndrome, Headache, Hyperventilation
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 31 year old, male patient. The patient's medical history included attention deficit disorder, epiglottis at age 3, tracheotomy, severe acne and vasectomy. Patient received FLUMIST (Intranasal) started on 31-Aug-2009. The patient experienced Guillain Barre syndrome which started on 12-Oct-2009. Patient had been having pain in legs requiring opioids, difficulty walking, leg weakness worse. Stands unsteady, drags right foot. Sensation and proprioception subjectively decreased in right leg. IVIG administered. Continued antalgic gait, pain in thighs. 18-Nov-2009 Physical Medicine Rehabilitation, additional hospital consults received service dates 29-Nov-2009 to 16-Nov-2009. Assessment: Relapse of Guillain-Barre Transferred from another hospital and admitted for rehabilitation for Guillain-Barre. Four weeks ago had weakness in upper and lower extremities, diagnosed with Guillain-Barre syndrome, treated with IVIG. Went to rehab and had seizure like episodes. on 04-Nov-2009 increased pain, increased weakness. Presumed diagnosis of relapse of Guillain-Barre with administration of IVIG. Possible seizure symptoms vs anxiety attack. Claustrophobia, Mild facial asymmetry. Deep tendon reflexes decreased. Pain inner thighs, legs hurt. Right-sided head pain diagnosed as migraine. Hands still painful. Numbness in feet persists. Complaints of vision problems and some difficulty urinating. Hyperventilation due to anxiety. Anxiety/Mood disorder. Patient complained of losing vision, dizziness, neuromuscular complaints. Eye exam was normal with exception of extraocular movements due to nystagmus. Neuro exam: normal. Patient presented to the hospital with extreme weakness, pain, trouble sleeping and anxious. Treatment: VICODIN, but no help. Patient saw a psychiatrist. Other treatment: XANAX, Klonopin, CYMBALTA. On examination, patient fatigued, anxiety, vision problems. Impression: Myopathy. Dr's opinion was that this was emotional related event. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event of Guillain Barre syndrome to be serious due to hospitalization. Laboratory values and diagnostic test details are available.
Age: 31.0
Sex: M
Vaccine: FLUN3
Symptoms: Hypoaesthesia, Hyporeflexia, Immunoglobulin therapy, Insomnia, Intervertebral disc degeneration
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 31 year old, male patient. The patient's medical history included attention deficit disorder, epiglottis at age 3, tracheotomy, severe acne and vasectomy. Patient received FLUMIST (Intranasal) started on 31-Aug-2009. The patient experienced Guillain Barre syndrome which started on 12-Oct-2009. Patient had been having pain in legs requiring opioids, difficulty walking, leg weakness worse. Stands unsteady, drags right foot. Sensation and proprioception subjectively decreased in right leg. IVIG administered. Continued antalgic gait, pain in thighs. 18-Nov-2009 Physical Medicine Rehabilitation, additional hospital consults received service dates 29-Nov-2009 to 16-Nov-2009. Assessment: Relapse of Guillain-Barre Transferred from another hospital and admitted for rehabilitation for Guillain-Barre. Four weeks ago had weakness in upper and lower extremities, diagnosed with Guillain-Barre syndrome, treated with IVIG. Went to rehab and had seizure like episodes. on 04-Nov-2009 increased pain, increased weakness. Presumed diagnosis of relapse of Guillain-Barre with administration of IVIG. Possible seizure symptoms vs anxiety attack. Claustrophobia, Mild facial asymmetry. Deep tendon reflexes decreased. Pain inner thighs, legs hurt. Right-sided head pain diagnosed as migraine. Hands still painful. Numbness in feet persists. Complaints of vision problems and some difficulty urinating. Hyperventilation due to anxiety. Anxiety/Mood disorder. Patient complained of losing vision, dizziness, neuromuscular complaints. Eye exam was normal with exception of extraocular movements due to nystagmus. Neuro exam: normal. Patient presented to the hospital with extreme weakness, pain, trouble sleeping and anxious. Treatment: VICODIN, but no help. Patient saw a psychiatrist. Other treatment: XANAX, Klonopin, CYMBALTA. On examination, patient fatigued, anxiety, vision problems. Impression: Myopathy. Dr's opinion was that this was emotional related event. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event of Guillain Barre syndrome to be serious due to hospitalization. Laboratory values and diagnostic test details are available.
Age: 31.0
Sex: M
Vaccine: FLUN3
Symptoms: Intervertebral disc protrusion, Loss of proprioception, Migraine, Muscular weakness, Muscular weakness
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 31 year old, male patient. The patient's medical history included attention deficit disorder, epiglottis at age 3, tracheotomy, severe acne and vasectomy. Patient received FLUMIST (Intranasal) started on 31-Aug-2009. The patient experienced Guillain Barre syndrome which started on 12-Oct-2009. Patient had been having pain in legs requiring opioids, difficulty walking, leg weakness worse. Stands unsteady, drags right foot. Sensation and proprioception subjectively decreased in right leg. IVIG administered. Continued antalgic gait, pain in thighs. 18-Nov-2009 Physical Medicine Rehabilitation, additional hospital consults received service dates 29-Nov-2009 to 16-Nov-2009. Assessment: Relapse of Guillain-Barre Transferred from another hospital and admitted for rehabilitation for Guillain-Barre. Four weeks ago had weakness in upper and lower extremities, diagnosed with Guillain-Barre syndrome, treated with IVIG. Went to rehab and had seizure like episodes. on 04-Nov-2009 increased pain, increased weakness. Presumed diagnosis of relapse of Guillain-Barre with administration of IVIG. Possible seizure symptoms vs anxiety attack. Claustrophobia, Mild facial asymmetry. Deep tendon reflexes decreased. Pain inner thighs, legs hurt. Right-sided head pain diagnosed as migraine. Hands still painful. Numbness in feet persists. Complaints of vision problems and some difficulty urinating. Hyperventilation due to anxiety. Anxiety/Mood disorder. Patient complained of losing vision, dizziness, neuromuscular complaints. Eye exam was normal with exception of extraocular movements due to nystagmus. Neuro exam: normal. Patient presented to the hospital with extreme weakness, pain, trouble sleeping and anxious. Treatment: VICODIN, but no help. Patient saw a psychiatrist. Other treatment: XANAX, Klonopin, CYMBALTA. On examination, patient fatigued, anxiety, vision problems. Impression: Myopathy. Dr's opinion was that this was emotional related event. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event of Guillain Barre syndrome to be serious due to hospitalization. Laboratory values and diagnostic test details are available.
Age: 31.0
Sex: M
Vaccine: FLUN3
Symptoms: Myopathy, Nerve conduction studies normal, Neurological examination normal, Neuromyopathy, Nuclear magnetic resonance imaging spinal abnormal
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 31 year old, male patient. The patient's medical history included attention deficit disorder, epiglottis at age 3, tracheotomy, severe acne and vasectomy. Patient received FLUMIST (Intranasal) started on 31-Aug-2009. The patient experienced Guillain Barre syndrome which started on 12-Oct-2009. Patient had been having pain in legs requiring opioids, difficulty walking, leg weakness worse. Stands unsteady, drags right foot. Sensation and proprioception subjectively decreased in right leg. IVIG administered. Continued antalgic gait, pain in thighs. 18-Nov-2009 Physical Medicine Rehabilitation, additional hospital consults received service dates 29-Nov-2009 to 16-Nov-2009. Assessment: Relapse of Guillain-Barre Transferred from another hospital and admitted for rehabilitation for Guillain-Barre. Four weeks ago had weakness in upper and lower extremities, diagnosed with Guillain-Barre syndrome, treated with IVIG. Went to rehab and had seizure like episodes. on 04-Nov-2009 increased pain, increased weakness. Presumed diagnosis of relapse of Guillain-Barre with administration of IVIG. Possible seizure symptoms vs anxiety attack. Claustrophobia, Mild facial asymmetry. Deep tendon reflexes decreased. Pain inner thighs, legs hurt. Right-sided head pain diagnosed as migraine. Hands still painful. Numbness in feet persists. Complaints of vision problems and some difficulty urinating. Hyperventilation due to anxiety. Anxiety/Mood disorder. Patient complained of losing vision, dizziness, neuromuscular complaints. Eye exam was normal with exception of extraocular movements due to nystagmus. Neuro exam: normal. Patient presented to the hospital with extreme weakness, pain, trouble sleeping and anxious. Treatment: VICODIN, but no help. Patient saw a psychiatrist. Other treatment: XANAX, Klonopin, CYMBALTA. On examination, patient fatigued, anxiety, vision problems. Impression: Myopathy. Dr's opinion was that this was emotional related event. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event of Guillain Barre syndrome to be serious due to hospitalization. Laboratory values and diagnostic test details are available.
Age: 31.0
Sex: M
Vaccine: FLUN3
Symptoms: Nystagmus, Pain, Pain in extremity, Seizure like phenomena, Sensory loss
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 31 year old, male patient. The patient's medical history included attention deficit disorder, epiglottis at age 3, tracheotomy, severe acne and vasectomy. Patient received FLUMIST (Intranasal) started on 31-Aug-2009. The patient experienced Guillain Barre syndrome which started on 12-Oct-2009. Patient had been having pain in legs requiring opioids, difficulty walking, leg weakness worse. Stands unsteady, drags right foot. Sensation and proprioception subjectively decreased in right leg. IVIG administered. Continued antalgic gait, pain in thighs. 18-Nov-2009 Physical Medicine Rehabilitation, additional hospital consults received service dates 29-Nov-2009 to 16-Nov-2009. Assessment: Relapse of Guillain-Barre Transferred from another hospital and admitted for rehabilitation for Guillain-Barre. Four weeks ago had weakness in upper and lower extremities, diagnosed with Guillain-Barre syndrome, treated with IVIG. Went to rehab and had seizure like episodes. on 04-Nov-2009 increased pain, increased weakness. Presumed diagnosis of relapse of Guillain-Barre with administration of IVIG. Possible seizure symptoms vs anxiety attack. Claustrophobia, Mild facial asymmetry. Deep tendon reflexes decreased. Pain inner thighs, legs hurt. Right-sided head pain diagnosed as migraine. Hands still painful. Numbness in feet persists. Complaints of vision problems and some difficulty urinating. Hyperventilation due to anxiety. Anxiety/Mood disorder. Patient complained of losing vision, dizziness, neuromuscular complaints. Eye exam was normal with exception of extraocular movements due to nystagmus. Neuro exam: normal. Patient presented to the hospital with extreme weakness, pain, trouble sleeping and anxious. Treatment: VICODIN, but no help. Patient saw a psychiatrist. Other treatment: XANAX, Klonopin, CYMBALTA. On examination, patient fatigued, anxiety, vision problems. Impression: Myopathy. Dr's opinion was that this was emotional related event. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event of Guillain Barre syndrome to be serious due to hospitalization. Laboratory values and diagnostic test details are available.
Age: 31.0
Sex: M
Vaccine: FLUN3
Symptoms: Visual impairment
Clinical narrative: This report to VAERS provides the following narrative: A report has been received from VAERS (Health Authority) concerning a 31 year old, male patient. The patient's medical history included attention deficit disorder, epiglottis at age 3, tracheotomy, severe acne and vasectomy. Patient received FLUMIST (Intranasal) started on 31-Aug-2009. The patient experienced Guillain Barre syndrome which started on 12-Oct-2009. Patient had been having pain in legs requiring opioids, difficulty walking, leg weakness worse. Stands unsteady, drags right foot. Sensation and proprioception subjectively decreased in right leg. IVIG administered. Continued antalgic gait, pain in thighs. 18-Nov-2009 Physical Medicine Rehabilitation, additional hospital consults received service dates 29-Nov-2009 to 16-Nov-2009. Assessment: Relapse of Guillain-Barre Transferred from another hospital and admitted for rehabilitation for Guillain-Barre. Four weeks ago had weakness in upper and lower extremities, diagnosed with Guillain-Barre syndrome, treated with IVIG. Went to rehab and had seizure like episodes. on 04-Nov-2009 increased pain, increased weakness. Presumed diagnosis of relapse of Guillain-Barre with administration of IVIG. Possible seizure symptoms vs anxiety attack. Claustrophobia, Mild facial asymmetry. Deep tendon reflexes decreased. Pain inner thighs, legs hurt. Right-sided head pain diagnosed as migraine. Hands still painful. Numbness in feet persists. Complaints of vision problems and some difficulty urinating. Hyperventilation due to anxiety. Anxiety/Mood disorder. Patient complained of losing vision, dizziness, neuromuscular complaints. Eye exam was normal with exception of extraocular movements due to nystagmus. Neuro exam: normal. Patient presented to the hospital with extreme weakness, pain, trouble sleeping and anxious. Treatment: VICODIN, but no help. Patient saw a psychiatrist. Other treatment: XANAX, Klonopin, CYMBALTA. On examination, patient fatigued, anxiety, vision problems. Impression: Myopathy. Dr's opinion was that this was emotional related event. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event of Guillain Barre syndrome to be serious due to hospitalization. Laboratory values and diagnostic test details are available.
Age: 20.0
Sex: M
Vaccine: FLUN3
Symptoms: Guillain-Barre syndrome
Clinical narrative: This report to VAERS provides the following narrative: A report from VAERS (Health Authority) concerns a 20 year old male. Patient's relevant history and concomitant disease were not reported. Patient received FLUMIST (intranasal) on 18-Sep-2009 and H1N1 (intranasal) on an unknown date. He experienced Guillain-Barre syndrome like symptoms. The outcome of the Guillain-Barre syndrome was unknown. The reporter considered the Guillain Barre syndrome to be serious by criteria of hospitalization and patient also required emergency room.
Age: 45.0
Sex: F
Vaccine: FLUN3
Symptoms: Alanine aminotransferase increased, Alpha-1 anti-trypsin normal, Antinuclear antibody negative, Aspartate aminotransferase increased, Blood creatine phosphokinase MB normal
Clinical narrative: This report to VAERS provides the following narrative: A report had been received from VAERS (Health Authority) concerning a 45 year old, female patient. Patient's relevant history and concomitant disease were not reported. Patient received FLUMIST (intranasal) on 24-Sep-2009. Patient became symptomatic mid-November with head pain and extremity weakness. Patient was admitted on 20-Nov-2009 and discharged 23-Nov-2009 with a diagnosis of extremity paresthesias and weakness. Patient readmitted on 02-Dec-2009 to 10-Dec-2009 because of persistent lower extremity weakness, numbness, tingling and upper extremity weakness. Patient was diagnosed with Guillain-Barre syndrome. Patient's labs included: CSF: WBC=1, Protein=99, Glucose=64, Culture negative, Thyroid studies high, CSF cell CT and culture normal, CRP and ESR normal, CBC, WBC and platelet high, Hgb and Hct low, CMP, AST and ALT high, Na low, CPK, Troponin and Lipase normal, Hepatitis panel, alpha-1 antitrypsin, ANA negative, Iron studies, TIBC and serum iron low. Action taken with FLUMIST was unknown. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event Guillain Barre syndrome to be serious with seriousness criteria of hospitalization and patient also required emergency room.
Age: 45.0
Sex: F
Vaccine: FLUN3
Symptoms: Blood creatine phosphokinase MB normal, Blood creatine phosphokinase normal, Blood iron decreased, Blood sodium decreased, C-reactive protein normal
Clinical narrative: This report to VAERS provides the following narrative: A report had been received from VAERS (Health Authority) concerning a 45 year old, female patient. Patient's relevant history and concomitant disease were not reported. Patient received FLUMIST (intranasal) on 24-Sep-2009. Patient became symptomatic mid-November with head pain and extremity weakness. Patient was admitted on 20-Nov-2009 and discharged 23-Nov-2009 with a diagnosis of extremity paresthesias and weakness. Patient readmitted on 02-Dec-2009 to 10-Dec-2009 because of persistent lower extremity weakness, numbness, tingling and upper extremity weakness. Patient was diagnosed with Guillain-Barre syndrome. Patient's labs included: CSF: WBC=1, Protein=99, Glucose=64, Culture negative, Thyroid studies high, CSF cell CT and culture normal, CRP and ESR normal, CBC, WBC and platelet high, Hgb and Hct low, CMP, AST and ALT high, Na low, CPK, Troponin and Lipase normal, Hepatitis panel, alpha-1 antitrypsin, ANA negative, Iron studies, TIBC and serum iron low. Action taken with FLUMIST was unknown. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event Guillain Barre syndrome to be serious with seriousness criteria of hospitalization and patient also required emergency room.
Age: 45.0
Sex: F
Vaccine: FLUN3
Symptoms: CSF culture negative, CSF glucose increased, CSF protein increased, CSF white blood cell count negative, Cardiac stress test normal
Clinical narrative: This report to VAERS provides the following narrative: A report had been received from VAERS (Health Authority) concerning a 45 year old, female patient. Patient's relevant history and concomitant disease were not reported. Patient received FLUMIST (intranasal) on 24-Sep-2009. Patient became symptomatic mid-November with head pain and extremity weakness. Patient was admitted on 20-Nov-2009 and discharged 23-Nov-2009 with a diagnosis of extremity paresthesias and weakness. Patient readmitted on 02-Dec-2009 to 10-Dec-2009 because of persistent lower extremity weakness, numbness, tingling and upper extremity weakness. Patient was diagnosed with Guillain-Barre syndrome. Patient's labs included: CSF: WBC=1, Protein=99, Glucose=64, Culture negative, Thyroid studies high, CSF cell CT and culture normal, CRP and ESR normal, CBC, WBC and platelet high, Hgb and Hct low, CMP, AST and ALT high, Na low, CPK, Troponin and Lipase normal, Hepatitis panel, alpha-1 antitrypsin, ANA negative, Iron studies, TIBC and serum iron low. Action taken with FLUMIST was unknown. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event Guillain Barre syndrome to be serious with seriousness criteria of hospitalization and patient also required emergency room.
Age: 45.0
Sex: F
Vaccine: FLUN3
Symptoms: Computerised tomogram head normal, Electrocardiogram normal, Full blood count normal, Guillain-Barre syndrome, Haematocrit decreased
Clinical narrative: This report to VAERS provides the following narrative: A report had been received from VAERS (Health Authority) concerning a 45 year old, female patient. Patient's relevant history and concomitant disease were not reported. Patient received FLUMIST (intranasal) on 24-Sep-2009. Patient became symptomatic mid-November with head pain and extremity weakness. Patient was admitted on 20-Nov-2009 and discharged 23-Nov-2009 with a diagnosis of extremity paresthesias and weakness. Patient readmitted on 02-Dec-2009 to 10-Dec-2009 because of persistent lower extremity weakness, numbness, tingling and upper extremity weakness. Patient was diagnosed with Guillain-Barre syndrome. Patient's labs included: CSF: WBC=1, Protein=99, Glucose=64, Culture negative, Thyroid studies high, CSF cell CT and culture normal, CRP and ESR normal, CBC, WBC and platelet high, Hgb and Hct low, CMP, AST and ALT high, Na low, CPK, Troponin and Lipase normal, Hepatitis panel, alpha-1 antitrypsin, ANA negative, Iron studies, TIBC and serum iron low. Action taken with FLUMIST was unknown. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event Guillain Barre syndrome to be serious with seriousness criteria of hospitalization and patient also required emergency room.
Age: 45.0
Sex: F
Vaccine: FLUN3
Symptoms: Haemoglobin decreased, Headache, Hepatitis A antibody negative, Hepatitis B test negative, Hepatitis C test negative
Clinical narrative: This report to VAERS provides the following narrative: A report had been received from VAERS (Health Authority) concerning a 45 year old, female patient. Patient's relevant history and concomitant disease were not reported. Patient received FLUMIST (intranasal) on 24-Sep-2009. Patient became symptomatic mid-November with head pain and extremity weakness. Patient was admitted on 20-Nov-2009 and discharged 23-Nov-2009 with a diagnosis of extremity paresthesias and weakness. Patient readmitted on 02-Dec-2009 to 10-Dec-2009 because of persistent lower extremity weakness, numbness, tingling and upper extremity weakness. Patient was diagnosed with Guillain-Barre syndrome. Patient's labs included: CSF: WBC=1, Protein=99, Glucose=64, Culture negative, Thyroid studies high, CSF cell CT and culture normal, CRP and ESR normal, CBC, WBC and platelet high, Hgb and Hct low, CMP, AST and ALT high, Na low, CPK, Troponin and Lipase normal, Hepatitis panel, alpha-1 antitrypsin, ANA negative, Iron studies, TIBC and serum iron low. Action taken with FLUMIST was unknown. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event Guillain Barre syndrome to be serious with seriousness criteria of hospitalization and patient also required emergency room.
Age: 45.0
Sex: F
Vaccine: FLUN3
Symptoms: Hepatitis viral test negative, Hepatobiliary scan, Hypoaesthesia, Iron binding capacity total decreased, Lipase normal
Clinical narrative: This report to VAERS provides the following narrative: A report had been received from VAERS (Health Authority) concerning a 45 year old, female patient. Patient's relevant history and concomitant disease were not reported. Patient received FLUMIST (intranasal) on 24-Sep-2009. Patient became symptomatic mid-November with head pain and extremity weakness. Patient was admitted on 20-Nov-2009 and discharged 23-Nov-2009 with a diagnosis of extremity paresthesias and weakness. Patient readmitted on 02-Dec-2009 to 10-Dec-2009 because of persistent lower extremity weakness, numbness, tingling and upper extremity weakness. Patient was diagnosed with Guillain-Barre syndrome. Patient's labs included: CSF: WBC=1, Protein=99, Glucose=64, Culture negative, Thyroid studies high, CSF cell CT and culture normal, CRP and ESR normal, CBC, WBC and platelet high, Hgb and Hct low, CMP, AST and ALT high, Na low, CPK, Troponin and Lipase normal, Hepatitis panel, alpha-1 antitrypsin, ANA negative, Iron studies, TIBC and serum iron low. Action taken with FLUMIST was unknown. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event Guillain Barre syndrome to be serious with seriousness criteria of hospitalization and patient also required emergency room.
Age: 45.0
Sex: F
Vaccine: FLUN3
Symptoms: Metabolic function test abnormal, Muscular weakness, Nuclear magnetic resonance imaging brain normal, Nuclear magnetic resonance imaging spinal normal, Nuclear magnetic resonance imaging thoracic normal
Clinical narrative: This report to VAERS provides the following narrative: A report had been received from VAERS (Health Authority) concerning a 45 year old, female patient. Patient's relevant history and concomitant disease were not reported. Patient received FLUMIST (intranasal) on 24-Sep-2009. Patient became symptomatic mid-November with head pain and extremity weakness. Patient was admitted on 20-Nov-2009 and discharged 23-Nov-2009 with a diagnosis of extremity paresthesias and weakness. Patient readmitted on 02-Dec-2009 to 10-Dec-2009 because of persistent lower extremity weakness, numbness, tingling and upper extremity weakness. Patient was diagnosed with Guillain-Barre syndrome. Patient's labs included: CSF: WBC=1, Protein=99, Glucose=64, Culture negative, Thyroid studies high, CSF cell CT and culture normal, CRP and ESR normal, CBC, WBC and platelet high, Hgb and Hct low, CMP, AST and ALT high, Na low, CPK, Troponin and Lipase normal, Hepatitis panel, alpha-1 antitrypsin, ANA negative, Iron studies, TIBC and serum iron low. Action taken with FLUMIST was unknown. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event Guillain Barre syndrome to be serious with seriousness criteria of hospitalization and patient also required emergency room.
Age: 45.0
Sex: F
Vaccine: FLUN3
Symptoms: Paraesthesia, Platelet count increased, Red blood cell sedimentation rate normal, Thyroid function test abnormal, Transaminases increased
Clinical narrative: This report to VAERS provides the following narrative: A report had been received from VAERS (Health Authority) concerning a 45 year old, female patient. Patient's relevant history and concomitant disease were not reported. Patient received FLUMIST (intranasal) on 24-Sep-2009. Patient became symptomatic mid-November with head pain and extremity weakness. Patient was admitted on 20-Nov-2009 and discharged 23-Nov-2009 with a diagnosis of extremity paresthesias and weakness. Patient readmitted on 02-Dec-2009 to 10-Dec-2009 because of persistent lower extremity weakness, numbness, tingling and upper extremity weakness. Patient was diagnosed with Guillain-Barre syndrome. Patient's labs included: CSF: WBC=1, Protein=99, Glucose=64, Culture negative, Thyroid studies high, CSF cell CT and culture normal, CRP and ESR normal, CBC, WBC and platelet high, Hgb and Hct low, CMP, AST and ALT high, Na low, CPK, Troponin and Lipase normal, Hepatitis panel, alpha-1 antitrypsin, ANA negative, Iron studies, TIBC and serum iron low. Action taken with FLUMIST was unknown. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event Guillain Barre syndrome to be serious with seriousness criteria of hospitalization and patient also required emergency room.
Age: 45.0
Sex: F
Vaccine: FLUN3
Symptoms: Troponin normal, White blood cell count increased
Clinical narrative: This report to VAERS provides the following narrative: A report had been received from VAERS (Health Authority) concerning a 45 year old, female patient. Patient's relevant history and concomitant disease were not reported. Patient received FLUMIST (intranasal) on 24-Sep-2009. Patient became symptomatic mid-November with head pain and extremity weakness. Patient was admitted on 20-Nov-2009 and discharged 23-Nov-2009 with a diagnosis of extremity paresthesias and weakness. Patient readmitted on 02-Dec-2009 to 10-Dec-2009 because of persistent lower extremity weakness, numbness, tingling and upper extremity weakness. Patient was diagnosed with Guillain-Barre syndrome. Patient's labs included: CSF: WBC=1, Protein=99, Glucose=64, Culture negative, Thyroid studies high, CSF cell CT and culture normal, CRP and ESR normal, CBC, WBC and platelet high, Hgb and Hct low, CMP, AST and ALT high, Na low, CPK, Troponin and Lipase normal, Hepatitis panel, alpha-1 antitrypsin, ANA negative, Iron studies, TIBC and serum iron low. Action taken with FLUMIST was unknown. The outcome of the event of Guillain Barre syndrome was unknown. The reporter considered the event Guillain Barre syndrome to be serious with seriousness criteria of hospitalization and patient also required emergency room.
Sex: F
Vaccine: FLUN3
Symptoms: Abortion spontaneous, Exposure during pregnancy
Clinical narrative: A report has been received from a literature source via regulatory authority, vaccine adverse event reporting system (VAERS) concerning a female patient. The patient's medical history, concomitant diseases and concomitant medications were not reported. On an unknown date, the patient received FLUMIST (intranasal) while she was pregnant. The patient had spontaneous abortion. The outcome of the event of drug exposure during pregnancy as well as of spontaneous abortion was unknown. The report was considered to serious due to important medical event and hospitalization criteria. Based on the information in this report, and awaiting the reporter's assessment, the company physician considered the event of spontaneous abortion to be not related to FLUMIST. The company causality was implied no for drug exposure during pregnancy.
Sex: U
Vaccine: FLUN3
Symptoms: Convulsion, Death
Clinical narrative: It is a spontaneous report to the VAERS program concerning a child patient with unknown gender and age. The patient's medical history, concurrent diseases, and concomitant medications were not reported. On an unknown date, the patient received nasal FLUMIST. Two days after vaccination, the patient had a seizure, and the patient died. The cause of death was seizure. Interval after vaccination unknown. According to the reporter the seizure was considered to be serious with the serious criteria of death.
Age: 7.0
Sex: F
Vaccine: FLUN4
Symptoms: Condition aggravated, Death, Mental status changes, Subacute sclerosing panencephalitis
Clinical narrative: A spontaneous health professional report from a regulatory authority in an article. Vaccine Adverse Event Reporting System (VAERS), July 2013-April 2014, concerns a 7 year old female. The patient's medical history included subacute sclerosing panencephalitis (SSPE). No concomitant diseases and concomitant medications were reported for consumer. Patient received Nasal FLUMIST QUADRIVALENT on an unknown date, and 64 days later she required hospitalization for 16 days for changes in mental status and progression of SSPE. The patient died from an unknown cause on an unspecified date. The report did not describe whether an autopsy was performed. The reporter assessed the death to be serious by the criterion of death.
Sex: U
Vaccine: FLUN4
Symptoms: Drug administration error
Clinical narrative: A report has been received from a Health Professional concerning children of unknown age and gender. The relevant history and concomitant disease of the patient were not reported. The concomitant medications of the patient were not provided. It was reported that nurse had removed the clip from the FLUMIST QUADRIVALENT (Intranasal) and gave some children the entire syringe of in one nostril on an unknown date. Action taken with FLUMIST QUADRIVALENT was unknown. The outcome of the event of some children have received a full dose of FLUMIST QUADRIVALENT on one nostril was unknown. The report was considered to be non-serious by reporter.
Age: 64.0
Sex: M
Vaccine: FLUN4
Symptoms: Product use issue
Clinical narrative: A report has been received from a Health Professional concerning a patient, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 28-Oct-2014. It was reported that a patient was dispensed FLUMIST QUADRIVALENT vaccine to the wrong patient population. The outcome of the event of administration to wrong patient population is unknown. The reporter's description of the event(s) was as follows: not provided. The report was considered to be non-serious.
Age: 60.0
Sex: F
Vaccine: FLUN4
Symptoms: Product use issue
Clinical narrative: A report has been received from a Health Professional concerning a patient, female subject, who had been receiving intramuscular FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 28-Oct-2014. The administration to wrong patient population was reported. The outcome of the event of administration to wrong population is unknown. The reporter's description of the event(s) was as follows: Not provided. The report was considered to be non-serious.
Age: 11.0
Sex: M
Vaccine: FLUN4
Symptoms: Influenza A virus test positive, Influenza like illness
Clinical narrative: A spontaneous report has been received from a Health professional concerning a 11 year old male patient of unknown ethnicity. The relevant history and concomitant disease of the patient were not reported. The concomitant medications of the patient were not provided. It was reported that the patient received FLUMIST QUADRIVALENT (intranasal) on 27-OCt-2014 at that office, and he came back on 31-Oct-2014 due to flu-like symptoms. Patient tested positive for Influenza A. Action taken was not applicable for FLUMIST QUADRIVALENT. The outcome of the events of tested positive for influenza A and flu-like symptoms was unknown. The events tested positive for influenza A and flu-like symptoms were considered to be non serious by the reporter.
Sex: M
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A report has been received from a physician concerning a patient, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. It was reported that the expired FLUMIST QUADRIVALENT had been administered to 12 patients. The outcome of the event of administered expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Age: 4.0
Sex: M
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A report has been received from a physician concerning a patient, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. It was reported that the patient was administered expired FLUMIST QUADRIVALENT on 08-Sep-2014. The outcome of the event of administered expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.
Age: 14.0
Sex: F
Vaccine: FLUN4
Symptoms: Expired product administered
Clinical narrative: A report has been received from a Physician concerning a 14 year old, female subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on an unknown date. It was reported that the patient was administered expired FLUMIST QUADRIVALENT on 08-Sep-2014. The outcome of the event of administered expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious.